nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC6A2—locus ceruleus—narcolepsy	0.079	0.146	CbGeAlD
Amphetamine—CARTPT—brainstem—narcolepsy	0.0489	0.0901	CbGeAlD
Amphetamine—CARTPT—forebrain—narcolepsy	0.0472	0.087	CbGeAlD
Amphetamine—CARTPT—Circadian rythm related genes—HCRTR2—narcolepsy	0.0454	0.0992	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—HCRTR1—narcolepsy	0.0454	0.0992	CbGpPWpGaD
Amphetamine—SLC6A2—autonomic nervous system—narcolepsy	0.042	0.0774	CbGeAlD
Amphetamine—CARTPT—medulla oblongata—narcolepsy	0.0341	0.0628	CbGeAlD
Amphetamine—TAAR1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0233	0.0509	CbGpPWpGaD
Amphetamine—CARTPT—Circadian rythm related genes—NPS—narcolepsy	0.0205	0.0449	CbGpPWpGaD
Amphetamine—CARTPT—brain—narcolepsy	0.0196	0.0361	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—P2RY11—narcolepsy	0.017	0.0372	CbGpPWpGaD
Amphetamine—SLC18A2—brainstem—narcolepsy	0.0166	0.0306	CbGeAlD
Amphetamine—SLC18A2—forebrain—narcolepsy	0.016	0.0296	CbGeAlD
Amphetamine—SLC6A3—brainstem—narcolepsy	0.0126	0.0232	CbGeAlD
Amphetamine—SLC6A3—forebrain—narcolepsy	0.0121	0.0224	CbGeAlD
Amphetamine—TAAR1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0116	0.0254	CbGpPWpGaD
Amphetamine—SLC18A2—medulla oblongata—narcolepsy	0.0116	0.0214	CbGeAlD
Amphetamine—SLC6A4—brainstem—narcolepsy	0.0115	0.0212	CbGeAlD
Amphetamine—SLC6A4—forebrain—narcolepsy	0.0111	0.0205	CbGeAlD
Amphetamine—MAOB—brainstem—narcolepsy	0.011	0.0202	CbGeAlD
Amphetamine—SLC6A4—Monoamine Transport—HRH3—narcolepsy	0.0108	0.0237	CbGpPWpGaD
Amphetamine—SLC18A2—midbrain—narcolepsy	0.0106	0.0195	CbGeAlD
Amphetamine—MAOB—forebrain—narcolepsy	0.0106	0.0195	CbGeAlD
Amphetamine—SLC6A2—brainstem—narcolepsy	0.0101	0.0187	CbGeAlD
Amphetamine—SLC6A2—forebrain—narcolepsy	0.00979	0.018	CbGeAlD
Amphetamine—SLC6A2—Monoamine Transport—HRH3—narcolepsy	0.00931	0.0204	CbGpPWpGaD
Amphetamine—DRD2—brainstem—narcolepsy	0.00924	0.017	CbGeAlD
Amphetamine—DRD2—forebrain—narcolepsy	0.00892	0.0164	CbGeAlD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0084	0.0184	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0084	0.0184	CbGpPWpGaD
Amphetamine—SLC6A3—Monoamine Transport—HRH3—narcolepsy	0.00825	0.018	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00811	0.0177	CbGpPWpGaD
Amphetamine—SLC6A3—midbrain—narcolepsy	0.00801	0.0148	CbGeAlD
Amphetamine—TAAR1—G alpha (s) signalling events—NPS—narcolepsy	0.00796	0.0174	CbGpPWpGaD
Amphetamine—MAOB—medulla oblongata—narcolepsy	0.00764	0.0141	CbGeAlD
Amphetamine—SLC6A4—midbrain—narcolepsy	0.00734	0.0135	CbGeAlD
Amphetamine—SLC6A2—medulla oblongata—narcolepsy	0.00707	0.013	CbGeAlD
Amphetamine—MAOB—midbrain—narcolepsy	0.00698	0.0129	CbGeAlD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0069	0.0151	CbGpPWpGaD
Amphetamine—SLC18A2—brain—narcolepsy	0.00666	0.0123	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—HCRTR1—narcolepsy	0.00639	0.014	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—HCRTR2—narcolepsy	0.00639	0.014	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—P2RY11—narcolepsy	0.00618	0.0135	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00615	0.0134	CbGpPWpGaD
Amphetamine—SLC22A5—medulla oblongata—narcolepsy	0.006	0.0111	CbGeAlD
Amphetamine—CYP2A6—brain—narcolepsy	0.00594	0.011	CbGeAlD
Amphetamine—DRD2—midbrain—narcolepsy	0.00589	0.0109	CbGeAlD
Amphetamine—CYP2D6—brainstem—narcolepsy	0.00555	0.0102	CbGeAlD
Amphetamine—SLC22A5—midbrain—narcolepsy	0.00548	0.0101	CbGeAlD
Amphetamine—DRD2—Amine ligand-binding receptors—HRH3—narcolepsy	0.00543	0.0119	CbGpPWpGaD
Amphetamine—CYP2D6—forebrain—narcolepsy	0.00536	0.00987	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—HCRT—narcolepsy	0.00525	0.0115	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00523	0.0114	CbGpPWpGaD
Amphetamine—SLC6A3—brain—narcolepsy	0.00503	0.00928	CbGeAlD
Amphetamine—SLC22A3—brain—narcolepsy	0.00474	0.00873	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—PENK—narcolepsy	0.00468	0.0102	CbGpPWpGaD
Amphetamine—SLC6A4—brain—narcolepsy	0.00461	0.0085	CbGeAlD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00458	0.01	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—HCRTR2—narcolepsy	0.00456	0.00998	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—HCRTR1—narcolepsy	0.00456	0.00998	CbGpPWpGaD
Amphetamine—MAOB—brain—narcolepsy	0.00439	0.00808	CbGeAlD
Amphetamine—SLC6A2—brain—narcolepsy	0.00406	0.00748	CbGeAlD
Amphetamine—TAAR1—GPCR ligand binding—TRH—narcolepsy	0.00398	0.0087	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0038	0.0083	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0038	0.0083	CbGpPWpGaD
Amphetamine—DRD2—brain—narcolepsy	0.0037	0.00682	CbGeAlD
Amphetamine—TAAR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00361	0.0079	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00361	0.0079	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00349	0.00763	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—HRH3—narcolepsy	0.00349	0.00763	CbGpPWpGaD
Amphetamine—SLC22A5—brain—narcolepsy	0.00345	0.00635	CbGeAlD
Amphetamine—TAAR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00328	0.00718	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00328	0.00718	CbGpPWpGaD
Amphetamine—DRD2—Monoamine GPCRs—HTR2A—narcolepsy	0.00322	0.00705	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—P2RY11—narcolepsy	0.00317	0.00693	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HCRT—narcolepsy	0.00297	0.00649	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—NPS—narcolepsy	0.00289	0.00632	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—TAC1—narcolepsy	0.00289	0.00632	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—HCRTR2—narcolepsy	0.00279	0.0061	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—HCRTR1—narcolepsy	0.00279	0.0061	CbGpPWpGaD
Amphetamine—DRD2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00271	0.00592	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HCRT—narcolepsy	0.00269	0.00589	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PENK—narcolepsy	0.00264	0.00578	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00253	0.00553	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PENK—narcolepsy	0.0024	0.00525	CbGpPWpGaD
Amphetamine—SLC6A4—Monoamine Transport—TNF—narcolepsy	0.00232	0.00508	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00229	0.005	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00229	0.005	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00228	0.005	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—TRH—narcolepsy	0.00225	0.00492	CbGpPWpGaD
Amphetamine—CYP2D6—brain—narcolepsy	0.00222	0.0041	CbGeAlD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00221	0.00483	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—NPS—narcolepsy	0.00206	0.00451	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—TRH—narcolepsy	0.00204	0.00447	CbGpPWpGaD
Amphetamine—SLC6A2—Monoamine Transport—TNF—narcolepsy	0.002	0.00437	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HRH3—narcolepsy	0.00197	0.00431	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00196	0.00428	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00196	0.00428	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HCRTR2—narcolepsy	0.00194	0.00424	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HCRTR1—narcolepsy	0.00194	0.00424	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00189	0.00414	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—P2RY11—narcolepsy	0.00187	0.00409	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—PENK—narcolepsy	0.0018	0.00394	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRH3—narcolepsy	0.00179	0.00392	CbGpPWpGaD
Amphetamine—SLC6A3—Monoamine Transport—TNF—narcolepsy	0.00177	0.00387	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—HTR2A—narcolepsy	0.00174	0.0038	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—NPS—narcolepsy	0.00163	0.00357	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—TAC1—narcolepsy	0.00163	0.00357	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00161	0.00352	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HCRT—narcolepsy	0.00159	0.00348	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00152	0.00332	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.00149	0.00326	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.00149	0.00326	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—NPS—narcolepsy	0.00148	0.00325	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—TAC1—narcolepsy	0.00148	0.00325	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00144	0.00315	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00143	0.00313	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PENK—narcolepsy	0.00142	0.0031	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.00134	0.00294	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CHKB—narcolepsy	0.00131	0.00287	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.00126	0.00276	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00125	0.00273	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.00122	0.00268	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00122	0.00267	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TRH—narcolepsy	0.00121	0.00264	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CHKB—narcolepsy	0.00111	0.00243	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PENK—narcolepsy	0.00109	0.00239	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00107	0.00234	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRH3—narcolepsy	0.00106	0.00231	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2A—narcolepsy	0.000983	0.00215	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TRH—narcolepsy	0.000928	0.00203	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR2A—narcolepsy	0.000893	0.00195	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CPT1B—narcolepsy	0.000891	0.00195	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000886	0.00194	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000886	0.00194	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NPS—narcolepsy	0.000877	0.00192	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TAC1—narcolepsy	0.000877	0.00192	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000843	0.00184	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000843	0.00184	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000814	0.00178	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000814	0.00178	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000765	0.00167	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000765	0.00167	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CPT1B—narcolepsy	0.000754	0.00165	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000739	0.00162	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000692	0.00151	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000674	0.00147	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000674	0.00147	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000654	0.00143	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CHKB—narcolepsy	0.000639	0.0014	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.000628	0.00137	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000622	0.00136	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000617	0.00135	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PENK—narcolepsy	0.00056	0.00123	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000533	0.00117	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2A—narcolepsy	0.000527	0.00115	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.000524	0.00115	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000476	0.00104	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.00046	0.00101	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000452	0.000989	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000452	0.000989	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000437	0.000955	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CPT1B—narcolepsy	0.000434	0.00095	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.000418	0.000913	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000406	0.000887	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TAC1—narcolepsy	0.000381	0.000833	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—NPS—narcolepsy	0.000381	0.000833	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HCRT—narcolepsy	0.000371	0.000812	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000358	0.000783	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TAC1—narcolepsy	0.000346	0.000757	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NPS—narcolepsy	0.000346	0.000757	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PENK—narcolepsy	0.000331	0.000724	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TRH—narcolepsy	0.000281	0.000615	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRH3—narcolepsy	0.000247	0.00054	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000244	0.000533	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	0.000229	0.000501	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—narcolepsy	0.000208	0.000455	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TAC1—narcolepsy	0.000204	0.000447	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NPS—narcolepsy	0.000204	0.000447	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—narcolepsy	0.000123	0.000269	CbGpPWpGaD
